This week on “The Top Line,” we break down the biggest stories out of JPM, from J&J’s blockbuster acquisition of ...

Radiotherapy, China's biotech surge and AI's role in drug discovery are notable topics that emerged from conversations on the ...

A major conference that took place earlier this month is set to return to San Francisco next year, according to SF Mayor Daniel Lurie’s office. The J.P. Morgan ...

Tevogen Bio Holdings Inc., a clinical-stage biotech firm specializing in immunotherapy, discussed its advancements in artificial intelligence (AI) during the J.P. Morgan Healthcare Conference.

What are biopharma VCs looking to invest in this year? Autoimmune disorders, osteoporosis, and cardiovascular disease are ...

On this edition of GEN Live, members of the GEN and Inside Precision Medicine (IPM) editorial teams who attended JPM join the ...

What does Trump's decision to leave the WHO mean for public health? And should U.S. companies be intimidated by Chinese drug ...

In an interview at the 43rd annual J.P. Morgan Healthcare Conference last week in San Francisco, Cohen said Talkspace is poised to treat additional Medicare and Medicare Advantage beneficiaries in ...

We recently compiled a list of the Top 10 Medical AI Stocks on Wall Street’s Radar. In this article, we are going to take a ...

today announced that its Chair & CEO Paul Romness has accepted an invitation to attend the 43 rd Annual J.P. Morgan Healthcare Conference in San Francisco, CA taking place on January 13-16 ...